RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
70 hedge funds and large institutions have $426M invested in Revance Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 11 closing their positions.
Holders
70
Holders Change
+1
Holders Change %
+1.45%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
31
Reduced
15
Closed
11
Calls
$427K
Puts
$560K
Net Calls
-$133K
Net Calls Change
-$87K
Top Buyers
| 1 |
1
Franklin Resources
San Mateo,
California
|
$70.4M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$25.4M |
| 3 |
GTC
3
Ghost Tree Capital
New York
|
$4.15M |
| 4 |
4
Bank of New York Mellon
New York
|
$24.1M |
| 5 |
VAM
5
Visium Asset Management
New York
|
$23.1M |
